Logo for Apellis Pharmaceuticals Inc

Apellis Pharmaceuticals Investor Relations Material

Latest events

Logo for Apellis Pharmaceuticals Inc

Study Result

Apellis Pharmaceuticals
Logo for Apellis Pharmaceuticals

Study Result

8 Aug, 2024
Logo for Apellis Pharmaceuticals

Q2 2024

1 Aug, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from Apellis Pharmaceuticals Inc

Access all reports
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company also engages in acquiring, developing and marketing complementary products for treating patients at various stages in their disease. Apellis Pharmaceuticals, Inc. was incorporated in 2009 and is based in Waltham, Massachusetts.